sulfamethoxazole has been researched along with Communicable Diseases, Emerging in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Actinomycosis is a chronic granulomatous condition that commonly manifests as cervicofacial, pulmonary, or abdominal disease, caused by slowly progressive infection with oral and gastrointestinal commensal Actinomyces species." | 1.35 | Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. ( Beovic, B; Blanche, S; Brousse, N; Galmiche, L; Güngör, T; Holland, SM; Kayal, S; Lopatin, U; Mahlaoui, N; Reichenbach, J; Seger, RA; Siler, U; Zbinden, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reichenbach, J | 1 |
| Lopatin, U | 1 |
| Mahlaoui, N | 1 |
| Beovic, B | 1 |
| Siler, U | 1 |
| Zbinden, R | 1 |
| Seger, RA | 1 |
| Galmiche, L | 1 |
| Brousse, N | 1 |
| Kayal, S | 1 |
| Güngör, T | 1 |
| Blanche, S | 1 |
| Holland, SM | 1 |
1 other study available for sulfamethoxazole and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.
Topics: Actinomyces; Actinomycosis; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bon | 2009 |